FASS logotyp
Vissa förpackningar receptfria

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Paracetamol NET

Evolan

Filmdragerad tablett 500 mg
(Vita till benvita kapselformade tabletter 16,5 x 8,25 mm med brytskåra på ena sidan.)

Analgetika och antipyretika, anilider

Aktiv substans:
ATC-kod: N02BE01
Läkemedel från Evolan omfattas av Läkemedelsförsäkringen.
Vad innebär restanmält läkemedel?
Information om restanmält läkemedel
Vissa förpackningar av Paracetamol NET Filmdragerad tablett 500 mg är restanmälda hos Läkemedelsverket. Kontrollera lagerstatus för att se om ditt apotek har läkemedlet i lager.

Kontakta ditt apotek eller din läkare om du har frågor.

Visa tillgänglig information från Läkemedelsverket

Blister 1 x 20 tablett(er) (vnr 559330)
Utbytbara läkemedel:
För närvarande finns restanmälda förpackningar för Paracetamol EQL Pharma.
Utbytbara läkemedel med jämförbara förpackningar enligt TLV.
Alvedon Novum (Filmdragerad tablett 500 mg) Blister 20 tablett(er) (vnr 379421)
Alvedon® (Filmdragerad tablett 500 mg) Blister 20 styck (vnr 097610)
Pamol (Filmdragerad tablett 500 mg) Blister 20 tablett(er) (vnr 060484)
Panodil® (Filmdragerad tablett 500 mg) Blister 20 styck (vnr 082808)
Paracetamol ABECE (Filmdragerad tablett 500 mg) Blister 20 tablett(er) (vnr 104633)
Paracetamol Apofri (Filmdragerad tablett 500 mg) Blister 20 tablett(er) (vnr 495312)
Paracetamol Orifarm (Filmdragerad tablett 500 mg) Blister 20 tablett(er) (vnr 377797)
Paracut (Tablett 500 mg) Blister 20 tablett(er) (vnr 403141)
Alternativ förpackning.
Startdatum: 2024-04-08
Prognos för slutdatum: 2024-08-30
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Miljöinformationen för paracetamol är framtagen av företaget Haleon Denmark för Alvedon, Alvedon Comp, Alvedon Novum, Alvedon®, Alvedon® forte, Panodil Brus Apelsin, Panodil® Duo, Therimin Honung & Citron, Therimin Skogsbär

Miljörisk: Användning av paracetamol har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Paracetamol bryts ned långsamt i miljön.
Bioackumulering: Paracetamol har låg potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation

Environmental Risk Classification

Predicted Environmental Concentration (PEC)

PEC is calculated according to the following formula:

PEC (μg/L) = (A*109*(100-R)/(365*P*V*D*100) = 1.5*10-6*0.85*A(100-98)

PEC = 1.61 μg/L

Where:

A = 537906 kg (total sold amount API in Sweden year 2019, data from IQVIA). No metabolism has been assumed in the PEC calculation.

R = 98% removal rate from waste water treatment plant (Reference 9)

P = number of inhabitants in Sweden = 9*106

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference 1)

D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (Reference 1)


Predicted No Effect Concentration (PNEC)

Ecotoxicological Studies

Green Algae (Scenedesmus subspicatus):

IC50 72h (growth) = 134,000 μg/L (OECD 201) (Reference 5)

Water flea (Daphnia magna):

Acute toxicity

EC50 48 h (immobility) = 9,200 μg/L (OECD 202) (Reference 7)

Zebra Fish (Brachydanio rerio):

Acute toxicity

LC50 96 h (lethality) = 378,000 μg/L (OECD 203) (Reference 5)

Green Algae (Chlorella vulgaris)

Chronic toxicity

NOEC 72 hours (growth) 46,000 ug/L (OECD 201) (Reference 13)

Water flea (Daphnia magna):

Chronic toxicity

NOEC 21 days (reproduction) = 1,000 μg/L (OECD 211) (Reference 10)

Fathead minnow (Pimephales promelas):

Chronic toxicity

NOEC (survival) = 460 μg/L (OECD 210) (Reference 11)


Microorganisms in activated sludge

EC50 3 hours (Inhibition) > 1,000,000 µg/L (OECD 209) (Reference 12)


PNEC = 460/10 = 46 μg/L

PNEC (μg/L) = lowest NOEC/10, where 10 is the assessment factor applied for three chronic NOECs.The NOEC for Fathead minnow (= 460 µg/L) has been used for this calculation since it is the most sensitive of the three tested species.


Environmental risk classification (PEC/PNEC ratio)

PEC/PNEC = 1.61/46 = 0.035, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase “Use of paracetamol has been considered to result in insignificant environmental risk.”


Degradation

Biotic degradation

Inherent degradability:

99% degradation in 5 days (OECD 302B) (Reference 3)


Simulation studies:

WWTP study:

Biodegradation constant = 58-80 L g-1ss d-1 (Reference 6)


Water-sediment study:

50% (DT50) degradation in 3.10 days days (OECD 308) (Reference 8)


Abiotic degradation

Hydrolysis:

Half-life, pH 7 > 1 year (TAD 3.09) (Reference 4)


Photolysis:

No Data


Justification of chosen degradation phrase:

Results of biological degradation: Inherent biodegradation = 99% in 5 days (OECD 302B, IUCLID data set). The substance is inherently biodegradable. The material is expected to be highly removed in wastewater treatment plants, 98% removal (Reference 9). This is supported by a measured biodegradation constant of 58-80 L g-1ss d-1 in a WWTP simulation test (Reference 6). Biodegradation constants greater than 10 are expected to result in greater than 90% biodegradation. Additionally, a DT50 of 3.1d and a DT90 of 10d was measured (Reference 8) using a water-sediment study (OECD 308) indicating a low potential for persistence. The phrase ‘Paracetamol is slowly degraded in the environment’ is thus chosen.


Bioaccumulation

Partitioning coefficient:

Log Pow = 0.51 at pH 7 (OECD 107) (Reference 3)


Justification of chosen bioaccumulation phrase:

Since log Pow < 4, the substance has low potential for bioaccumulation.


Excretion (metabolism)

85% of the dose is excreted in urine within 24 hrs as free and conjugated paracetamol (Reference 4). For purposes of the risk assessment assume conjugates are converted back into free paracetamol (Reference 2).


PBT/vPvB assessment

Paracetamol does not fulfil the criteria for PBT and/or vBvP.

All three properties, i.e. ‘P’, ‘B’ and ‘T’ are required in order to classify a compound as PBT (Reference 1). Paracetamol does not fulfil the criteria for PBT and/or vBvP based on a log Dow < 4.


Please, also see Safety data sheets on http://www.msds-gsk.com/ExtMSDSlist.asp.


References

  1. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment.

  2. Pharmacokinetic properties: Metabolism and Elimination. Summary of Product Characteristics Ziagen (Paracetamol) 300mg Film Coated Tablets. ViiV Healthcare UK Ltd., March 2013.

  3. European Chemicals Bureau 2000. IUCLID Dataset Paracetamol.

  4. AHFS Drug Information, 2002. American Society of Health-System Pharmacists.

  5. Henschel, K., Wenzel, A., Diedrich,M., Fliedner, A. 1997. Regulatory Toxicology and Pharmacology 25, 220-225.

  6. Joss, A., et al. 2006. Water Research 40, 1686-1696.

  7. Kuhn, R., Pattard, M., Pernak, KD.,Winter, A. 1989. Water Research 23, No.4, 495-499.

  8. Loffler, D., Rombke, J., Meller, M., Ternes, T. 2005. Environmental Science and Technology 39, 5209-5218.

  9. Ternes, T. 1998. Water Research 32, No.11 3245-3260.

  10. [Smithers Viscient AG Study No. 1162.000.230] 4’Hydroxyacetanilide: Chronic reproduction test with daphnids (Daphnia magna) under semi-static conditions OECD No. 211, Dated August 11, 2011.

  11. [Smithers Viscient AG Study No. 1162.000.122] 4’-Hydroxyacetanilide: Early life-stage toxicity test with fathead minnow (Pimephales promelas) under flow-through conditions, OECD 210, Dated October 14, 2011.

  12. [Smithers Viscient AG Study No. 1162.000.790] 4’-Hydroxyacetanilide: Activated sludge respiration inhibition test, OECD # 209, Dated August 8, 2011

  13. ECHA REACH Registration Paracetamol. National Institute of Technology and Evaluation. 1998. Toxicity to aquatic algae and cyanobacteria.https://echa.europa.eu/registration-dossier/-/registered-dossier/12532/1/2